Clinical Trials Browser

Phase 2 × Breast Neoplasms × tocilizumab × Clear all

NCT04871854 2022-11-01

Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints

Phase 2 Completed

Breast Neoplasms